AA end lectures Flashcards

1
Q

What are the aims for targeted therapy

A

limit side effects from infection and antibiotic
reduce development of antibiotic resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is empirical therapy

A

Using antibiotics through statistical guessing
e.g. purulent tonsilitis - streptococcus pyogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how does age affect antibiotic use

A

Advanced age
- gastric acidity reduced
- Renal function deteriorating
o Toxicities of antibiotics increase  retained longer = hepatic and renal problems/ failure
- Allergic reaction increase

Children
- Underdeveloped liver function
- Renal function diminished = reduced antibiotic clearance
o Tetracycline = teeth staining
o Quinolones alter cartilage development
o Sulfonamides displace bilirubin = neurotoxic

Pregnancy
- Not safe – can pass across placenta and affect neonate
o Doxycycline, tetracycline
o Sulfonamide
o Aminoglycosides
- Penicillin, cephalosporins and clindamycin – safe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does renal and liver function affect antimicrobial

A

Renal function
- Metabolised or excreted by kidneys
- Half life increases with impaired kidney function

Liver function
- Half life increase with impaired liver = toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does site of infection affect antimicrobial

A

Site accessibility may be affected by lipid solubility
- Metronidazole and rifampicin are lipid soluble drugs
o Better penetrate BBB

Abscesses
- Antibiotics cannot penetrate
- Purulent material may present – binds and inactivates aminoglycosides
- Low O2 concentration and low pH
o Aminoglycosides requires O2 for transport
o Reduce activity of erythromycin

Medicinal devices and biofilms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are biofilms

A
  • Matrix provides physical barrier to diffusion of molecules
  • Deeper layers of biofilm are anaerobic and also organism have low metabolic activity there
    o Quinolones and aminoglycosides work poorly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some reasons for topical therapy

A
  • Targeted
    o Can achieve high concentration at the site
  • Less collateral damage
  • Enables the use of agents too toxic for systemic use
  • Avoids first pass metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are factors affecting effectiveness of topical antimicrobials

A

Some areas requiring treatment are inaccessible
Biological fluids may prevent agents from reaching site
Patient compliance
Topical agents may be more difficult to apply
Formulation may affect acceptability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are antiseptics

A

Agents used for destruction or inhibition of microbes in or on living tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What medications can you use to treat MRSA

A

Clindamycin – 300-450mg tds
o 30% are resistant

Doxycycline 100mg bd
o 100% susceptibility

Trimethoprim/ sulfamethoxazole
o 95% susceptible

Rifampicin and fusidic acid

Quinolones – ciprofloxacin

Vancomycin
o 25 mg/kg loading dose to 15-20 mg/kg bd

Linezolid
o Oxazolidinone
 Inhibits protein synthesis

Daptomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is melioidosis

A

Caused by Burkholderia pseudomallei

Transmission:
- Cutaneous, inhalation, aspiration and occasionally ingestion
- Can appear asymptomatic

Clinical presentations
- Most infections are subclinical
- Most common clinical manifestation is pneumonia then skin infections
- Bacteraemia and septic shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are antimicrobials that melioidosis are resistant to

A

Antimicrobial resistance
- Resistant penicillin, ampicillin, first and second generation cephalosporins, gentamicin, tobramycin and streptomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Exclusion from the cell melioidosis

A

Exclusion from the cell
o Reduced outer membrane permeability
o LPS contributes to intrinsic high-level polymyxin B resistance
o Lipid A modification by 4-amino-4-deoxy-L-arabinose
o LPS O-antigen and outer core components are important in resistance to cationic antimicrobial peptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Efflux from the cell melioidosis

A
  • Efflux from the cell
    o AmrAB-OprB
     Aminoglycoside and macrolide resistance
    o BpeAB-OprB
     Macrolides, fluoroquinolones, tetracyclines
    o BpeEF-OprC
     Trimethoprim resistance
     Chloramphenicol, fluoroquinolones and tetracyclines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Enzymatic inactivation melioidosis

A
  • Enzymatic inactivation
    o Cleavage of B-lactam antibiotics by PenA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Altered target site melioidosis

A
  • Altered target sites
    o Target deletion
    o Ceftazidime resistance mechanism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Acquired antimicrobial resistance melioidosis

A
  • Mutations or horizontal gene transfer mediated by phages, plasmids or transposon elements
  • Ceftazidime
    o Loss of gene required for synthesis of a penicillin binding protein 3
    o Point mutation on PenA resulting in amino acid changes = increased ceftazimide hydrolysis
    o Upregulation of penA via SNP in promoter region
  • Clavulanic acid
    o Mutations in P167S
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are probiotic therapy

A

Live micro-organism that when administered in adequate amounts, confer health benefit on the host
Ideal characteristics of probiotic organisms
- Non-pathogenic
- Easily cultivated
- Adherent
- Able to form a stable population at site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are uses of probiotics

A
  • Active treatment or as preventative
    o To restore, rebalance and support normal flora
  • Used for gastrointestinal and urogenital tract infections
  • Administered by
    o Ingesting capsules, drinks or applying pessaries to site
20
Q

Mechanism of action of probiotics

A

General mechanism
- Competitive inhibition for sites/ nutrients
- Antagonism through production of inhibitory substances
- Inhibition of toxin produced by pathogens
- Immunodomulation of the host

Lactobacilli
- Production of lactic acid
- Production of antimicrobial substances
- Production of hydrogen peroxide
- Formation of colonisation barrier

21
Q

What are bacteriocins

A
  • Antimicrobial peptides
  • Produced by wide range of organism

Mechanism of action
- Form pores in bacterial cell membrane
- Narrow spectrum activity

22
Q

What are probiotic yeast

A

Mechanism of action
- Secretes a protease that
o Digests toxin A and B molecules
o Digests toxin A and B receptors on brush border membrane

23
Q

Faecal microbiota transplantation

A

Transplanted into unhealthy recipient
- Recipient has reduced microbial diversity
- Transplanted via nasogastric tube or colonoscopy
Donors must be healthy
- Donor blood and stool are screened

Mechanism of action
- Transplant flora establishes in recipient
o Restore gut flora
- Increases microbial diversity in recipient compared to pre-transplant

24
Q

Bacteriophage therapy

A

Mechanism of action
- Phage lyses bacterial cells resulting in bacterial cell death

25
Q

Stages of bacteriophage

A
  • Phage infects bacteria
  • Phage replicates using bacterial cell machinery
  • Lyses bacteria and new phage released
  • New phage infect other bacteria
26
Q

advantages and disadvantages of bacteriophage

A

Advantages:
- Phages are highly specific
- Effective against MDR
- No overgrowth of bacteriophages
- No deleterious effects on host cell
- Relatively cheap

Disadvantages:
- Bioavailability
o Reduced with stomach acid
- Safety concern
o Development of phage antibody by host
o Bacterial toxin present in pahge preparation
o Lysogenic conversion
- Other
o Some MRSA less susceptible to phage
o Bacteria may develop phage resistance

27
Q

Garlic

A

Antimicrobial action from allicin
- Breaks down into sulfides = very potent against bacteria and fungi

Mechanism of action
- Allicin interferes with thiol containing enzymes
o Forms disulfide bonds with protonated sulfhydryl groups
o Inactivates protein in key microbial processes

28
Q

Cranberry

A
  • For urinary tract infections
  • Active components are proanthocyanidins

Mechanism of action
- Reduces E.coli expression of fimbriae
- Reduces E.coli adhesion and binding to epithelial cells

29
Q

Green tea

A
  • Traditional Chinese medicine used to treat a range of general ailments
  • Contains catechins
    o Phenolic compounds
    o Flavonoids
    o Anti-oxidant activity

Mechanism of action
- Antiviral
- Weak antibacterial
- Weak antifungal
- Immune-stimulatory

30
Q

Qinghaosu

A
  • Contains artemisinin

Mechanism of action
- Against plasmodium still investigated

31
Q

Honey

A
  • Mostly sugar

Mechanism of action
- Antibacterial activity against a range
- Due to
o High osmolarity/ low water availability
o Low pH
o Generation of hydrogen peroxide
o Other minor component

32
Q

Tea tree oil

A
  • Mostly terpenes

Mechanism of action
- Broad spectrum antimicrobial activity
- Loss of cell membrane polarity and integrity
- Loss of cell homeostasis
- Inhibition of respiration
- Anti-inflammatory activity

33
Q

Target selection

A

decision to focus on finding an agent with a particular biological action that is anticipated to have therapeutic utility

34
Q

Target identification

A

to identify molecular targets that are required for microbial growth or target a human gene

35
Q

Target validation

A

to prove that manipulating the molecular target can provide therapeutic benefit for patients

36
Q

Genomics

A

study of genes and their function

37
Q

Proteomics

A

study of proteome, the complete set of proteins produced by a species using technologies of large scale protein separation and identification

38
Q

Lead discovery

A

identification of small molecule modulators of protein function

39
Q

High throughput screening

A

screening of drug target against selection of chemicals

40
Q

Silico screening

A

computer simulated screening of chemicals

41
Q

Drug affinity

A

ability of drug to bind to its biological target

42
Q

Selectivity

A

drug should bind to specific receptor site on the cell

43
Q

Animal models of disease states

A

test conditions involving induced disease or injury similar to human conditions

44
Q

Behavioural studies

A

tools to investigate behavioural results of drugs

45
Q

Functional imaging

A

method of detecting or measuring changes in metabolism, blood flow, regional chemical composition and absorption

46
Q

Ex-vivo studies

A

experimentation on tissue in an artificial environment outside the organism with the minimum alteration of natural conditions

47
Q

Clinical trials

A

set of procedures in medicinal research and drug development to study the safety and efficacy of new drug